Lactase for infantile colic: A systematic review of randomized clinical trials

Angélica Luciana Nau1, Amanda Santiago Bassan2, Alessandra Bacelar Cezar3

  • 1Division of Pediatric Gastroenterology, Hospital Jaraguá, Jaraguá do Sul, Brazil.

Insights

Lactase supplementation shows mixed results for treating infantile colic, with some studies indicating reduced crying time and others finding no significant difference. Further research is needed to clarify its efficacy.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Evidence-based Medicine

Background:

  • Infantile colic is characterized by excessive crying in healthy infants, with unclear physiopathology.
  • Current therapies often focus on gastrointestinal symptoms.
  • Lactase supplementation is explored as a potential treatment targeting lactose digestion.

Purpose of the Study:

  • To systematically review randomized controlled trials (RCTs) assessing the efficacy of lactase supplementation for infantile colic.
  • To evaluate the impact of lactase on crying duration and gastrointestinal symptoms in infants.

Main Methods:

  • Systematic review of RCTs sourced from PubMed, Embase, and Cochrane databases.
  • Included infants up to 6 months old diagnosed with infantile colic.
  • Analyzed data from six RCTs involving 394 participants.

Main Results:

  • Three of the six RCTs reported a significant reduction in crying time with lactase supplementation compared to placebo.
  • The remaining three RCTs found no significant difference in crying time between the lactase and placebo groups.
  • Hydrogen breath tests showed inconsistent results, with only one study reporting a significant reduction in exhaled hydrogen levels.

Conclusions:

  • The efficacy of lactase supplementation for infantile colic remains inconclusive.
  • The pharmacological approach to infantile colic requires further investigation.
  • Standardized diagnostic criteria and outcome measures are necessary for future studies on lactase supplementation.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331